Managing Intrathecal Drug Delivery (ITDD) in Cancer Patients

被引：10
作者：
Shah, Rajiv [1 ]
Baqai-Stern, Aisha [2 ]
Gulati, Amitabh [2 ]
机构：
[1] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, Board Certified Anesthesiol & Pain Management, M308, New York, NY 10065 USA
来源：
CURRENT PAIN AND HEADACHE REPORTS | 2015年 / 19卷 / 06期
关键词：
Intrathecal drug delivery; Intrathecal medications; Cancer pain; Neuraxial trial; CHRONIC PAIN; MANAGEMENT; RECOMMENDATIONS; SELECTION; THERAPY; SYSTEM; IMPACT;
D O I：
10.1007/s11916-015-0488-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Pain is a commonly reported symptom in cancer patients. Patients with cancer pain often fail conservative medical management or have significant side effects to systemic medications. The implantation of an intrathecal drug delivery (ITDD) system may be the most effective treatment option for these patients and can improve their quality of life. This article aims to discuss the choice of intrathecal medications for patients suffering from intractable cancer pain, the management of ITDD throughout a patient's disease course, and the management of complications related to the ITDD system and intrathecal medications.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies
    Perruchoud, Christophe
    Dupoiron, Denis
    Papi, Bianca
    Calabrese, Alessandra
    Brogan, Shane E.
    NEUROMODULATION, 2023, 26 (06): : 1142 - 1152
  • [32] Randomised, double- blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain
    Raphael, Jon H.
    Duarte, Rui V.
    Southall, Jane L.
    Nightingale, Peter
    Kitas, George D.
    BMJ OPEN, 2013, 3 (07):
  • [33] History and Present State of Targeted Intrathecal Drug Delivery
    Syed Rizvi
    Krishna Kumar
    Current Pain and Headache Reports, 2015, 19
  • [34] Cancer patients quality of life after intrathecal drug delivery for advanced pain management: a patient-reported outcome analysis
    Goel, Vasudha
    Kaizer, Alexander
    Darrow, David
    Rosielle, Drew
    Owens, Benjamin
    Blaes, Anne
    PAIN MEDICINE, 2025, 26 (05) : 261 - 268
  • [35] Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management
    Stearns, Lisa J.
    Hinnenthal, Jennifer A.
    Hammond, Krisstin
    Berryman, Eric
    Janjan, Nora A.
    NEUROMODULATION, 2016, 19 (02): : 196 - 205
  • [36] Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain
    Fangfang Xing
    R. Jason Yong
    Alan David Kaye
    Richard D. Urman
    Current Pain and Headache Reports, 2018, 22
  • [37] Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain
    Xing, Fangfang
    Yong, R. Jason
    Kaye, Alan David
    Urman, Richard D.
    CURRENT PAIN AND HEADACHE REPORTS, 2018, 22 (02)
  • [38] Intrathecal morphine combined with ropivacaine induces spinal myoclonus in cancer patients with an implanted intrathecal drug delivery system Three case reports
    Guo, Xuejiao
    Li, Yunze
    Yang, Yixin
    Zhao, Yimin
    Guo, Jianguo
    Zhang, Yanfeng
    Peng, Zhiyou
    Feng, Zhiying
    MEDICINE, 2019, 98 (18)
  • [39] Current perspectives on intrathecal drug delivery
    Bottros, Michael M.
    Christo, Paul J.
    JOURNAL OF PAIN RESEARCH, 2014, 7 : 615 - 626
  • [40] Intrathecal Drug Delivery System: A Pain Management Option for Refractory Cancer-Related Pain
    Wanderman, Robalee L.
    Hagedorn, Jonathan M.
    PAIN MEDICINE, 2021, 22 (02) : 523 - 526
12345